Health Care: Drugs

Exelixis Inc (EXEL: NASDAQ)

$21.52 -1.57 | -6.8%
02/28/17 - 10:01 AM ET
Company Cash Flow
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Cash Flow From Operating Activities
Net Income (Loss) -169.74M -268.54M -244.76M -147.65M
Operating Gains/Losses -112.00K -838.00K 0.00 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -646.00K -941.00K -1.19M 27.04M
(Increase) Decrease in Inventories -235.00K 509.00K -2.89M 0.00
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables -1.28M -13.95M 8.69M 5.15M
(Decrease) Increase In Other Current Liabilities 10.21M 732.00K 0.00 0.00
(Increase) Decrease In Other Working Capital -33.57M 1.84M -7.91M -39.06M
Other Non-Cash Items 27.67M 12.33M 18.82M 12.87M
Net Cash From Continuing Operations -141.59M -235.41M -198.77M -123.15M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -141.59M -235.41M -198.77M -123.15M
Sale of Property, Plant & Equipment 1.35M 392.00K 143.00K 1.94M
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -447.00K -474.00K -2.17M -2.72M
Acquisitions 95.00K 838.00K 0.00 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities 14.14M 12.21M 11.18M -35.99M
Cash Provided by Financing Activities
Net Cash From Investing Activities 50.08M 146.33M 144.35M -259.47M
Issuance of Debt 0.00 0.00 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 157.13M 77.20M 1.50M 205.62M
Repayment of Long-Term Debt -4.38M -11.71M -13.17M -4.87M
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 0.00 0.00 0.00 277.67M
Net Cash From Financing Activities 152.75M 65.49M -11.67M 478.43M
Effect of Exchange Rate Changes 0.00 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents 61.24M -23.58M -66.09M 95.81M

Portfolios with EXEL

Latest EXEL Headlines from TheStreet

More Financial News for EXEL

Press Releases for EXEL

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter